all report title image

NASAL LACRIMAL STENT MARKET ANALYSIS

Nasal Lacrimal Stent Market, by Product Type (Bicanalicular Stent and Monocanalicular Stent), by Application (Epiphora, Dacryocystorhinostomy (DCR), and Congenital Nasolacrimal Obstruction) End User (Hospitals and Ophthalmic Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI3183
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Regional Analysis

Nasal Lacrimal Stent Market- Regional Analysis

On the basis of region, the nasal lacrimal stent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the nasal lacrimal stent market during the forecast period, as key market players are focused on expanding their presence in the North America region. For instance, in Jan, 2019, FCI Ophthalmics entered an agreement with Carl Zeiss Canada Ltd. regarding the distribution of FCI Ophthalmics' range of lacrimal stents and tubes, which include Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (Bicanicular stent) in Canada.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.